SECTION 1?Cancer Prevention & Screening
Chapter 1?Cancer Screening Trials
Chapter 2?Cancer Risk Prediction Models
Chapter 3?Incorporating External Registry Data Into Cohort-based Cancer Risk Prediction Tools
?
SECTION 2?Trial Design | Early-Phase Trials
Chapter 4?Phase I Overview and Recent Trial Designs
Chapter 5?Statistical and Machine Learning Methods for Phase I Dose-Finding
Chapter 6?Seamless Phase I/II Trial Design for Assessing Toxicity and Efficacy?for Targeted Agents
Chapter 7?Designs Using Time to Event Endpoints / Single Arm versus Randomized Phase II Designs
Chapter 8?Phase II Selection Designs
Chapter 9?Phase II Trials with Multiple Strata
SECTION 3?Trial Design | Late-Phase Trials
Chapter 10?Cure Rate Survival Models
Chapter 11 Phase III Trials for Targeted Agents
Chapter 12?Phase II and III Clinical Trial Designs for Precision Medicine
Chapter 13?SMARTs in Oncology
Chapter 14?Statistical Considerations in the Design and Analysis of Cancer Trials with Immune-Oncology Therapies
Chapter 15?Alpha Splitting
Chapter 16?Early Stopping of Clinical Trials Evaluating Targeted Therapies
Chapter 17?Noninferiority Trials
Chapter 18?Considerations for Pediatric Oncology Trials
?
SECTION 4?Trial Conduct
?
Chapter 19?An Overview of Master Protocols